Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study

[1]  Bin Wang,et al.  Green tea, black tea consumption and risk of lung cancer: a meta-analysis. , 2009, Lung cancer.

[2]  Markus Horneber,et al.  Green tea (Camellia sinensis) for the prevention of cancer. , 2009, The Cochrane database of systematic reviews.

[3]  V. Adhami,et al.  Effective Prostate Cancer Chemopreventive Intervention with Green Tea Polyphenols in the TRAMP Model Depends on the Stage of the Disease , 2009, Clinical Cancer Research.

[4]  S. Mousa,et al.  Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. , 2009, Cancer research.

[5]  S. Kuriyama,et al.  Case–control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma , 2009, Cancer Causes & Control.

[6]  D. Christiani,et al.  A population-based, case–control study of green tea consumption and leukemia risk in southwestern Taiwan , 2009, Cancer Causes & Control.

[7]  Zhìhóng Hú,et al.  Green tea extract and its major component epigallocatechin gallate inhibits hepatitis B virus in vitro. , 2008, Antiviral research.

[8]  Di Chen,et al.  Prodrugs of Fluoro-Substituted Benzoates of EGC as Tumor Cellular Proteasome Inhibitors and Apoptosis Inducers , 2008, International journal of molecular sciences.

[9]  G. Fattovich,et al.  Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. , 2008, Journal of hepatology.

[10]  C. Holman,et al.  Possible protective effect of green tea intake on risk of adult leukaemia , 2007, British Journal of Cancer.

[11]  F. Azzaroli,et al.  Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations. , 2006, World journal of gastroenterology.

[12]  Shinichi Kuriyama,et al.  Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. , 2006, JAMA.

[13]  S. Kuriyama,et al.  No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study , 2006, British Journal of Cancer.

[14]  M. Jo,et al.  A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. , 2006, Journal of hepatology.

[15]  Xudong Tang,et al.  Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1α protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells , 2006, Molecular Cancer Therapeutics.

[16]  西川 太一朗.  A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins , 2006 .

[17]  Xudong Tang,et al.  Green tea extract and (-)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. , 2006, Molecular cancer therapeutics.

[18]  S. Kuriyama,et al.  Coffee consumption and the risk of primary liver cancer: Pooled analysis of two prospective studies in Japan , 2005, International journal of cancer.

[19]  M. Inoue,et al.  Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. , 2005, Journal of the National Cancer Institute.

[20]  E. Platz,et al.  Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. , 2004, American journal of epidemiology.

[21]  J. Tanaka,et al.  Sex- and Age-Specific Carriers of Hepatitis B and C Viruses in Japan Estimated by the Prevalence in the 3,485,648 First-Time Blood Donors during 1995–2000 , 2004, Intervirology.

[22]  T. Ueno,et al.  Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. , 2004, Journal of hepatology.

[23]  Kiyohiko Mabuchi,et al.  A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan) , 2004, Cancer Causes & Control.

[24]  T. Ohkubo,et al.  Validation of a food-frequency questionnaire for cohort studies in rural Japan , 2003, Public Health Nutrition.

[25]  G. Qin,et al.  Chemoprevention of Aflatoxin B1-Initiated and Carbon Tetrachloride-Promoted Hepatocarcinogenesis in the Rat by Green Tea , 2000, Nutrition and cancer.

[26]  J. Trosko,et al.  Prevention of the down-regulation of gap junctional intercellular communication by green tea in the liver of mice fed pentachlorophenol. , 2000, Carcinogenesis.

[27]  L. Patrick.  Hepatitis C: epidemiology and review of complementary/alternative medicine treatments. , 1999, Alternative medicine review : a journal of clinical therapeutic.

[28]  T. Ohkubo,et al.  A prospective cohort study on National Health Insurance beneficiaries in Ohsaki, Miyagi Prefecture, Japan: study design, profiles of the subjects and medical cost during the first year. , 1998, Journal of epidemiology.

[29]  Y. Konishi,et al.  Inhibition by Green Tea Extract of Diethylnitrosamine–initiated but Not Cholinedeficient, L–Amino Acid–defined Diet–associated Development of Putative Preneo–plastic, Glutathione S–Transferase Placental Form–positive Lesions in Rat Liver , 1997, Japanese journal of cancer research : Gann.

[30]  G. Qin,et al.  Inhibition of aflatoxin B1-induced initiation of hepatocarcinogenesis in the rat by green tea. , 1997, Cancer letters.

[31]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.